Agilent Technologies, Inc.
A
NYSE
Last Updated: 6/9/2023 8:03:01 PM
High
Low
About Agilent Technologies, Inc.
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.Agilent Technologies, Inc. Company Details
CEO: Mr. Michael R. McMullen
Country: US
Industry: Diagnostics & Research
Website: https://www.agilent.com
Exchange: New York Stock Exchange
IPO\Launch Date: 1999-11-18
Agilent Technologies, Inc. Company Executive Details
Mr. Michael R. McMullen
Chief Executive Officer, Pres & Director
Mr. Samraat S. Raha
Senior Vice President and Pres of Diagnostics & Genomics Group
Dr. Darlene J. S. Solomon Ph.D.
Chief Technology Officer & Senior Vice President
Mr. Padraig McDonnell
Senior Vice President & Pres of Agilent Cross Lab Group
Mr. Michael Tang
Senior Vice President, Gen. Counsel & Sec.
Agilent Technologies, Inc. Latest News
Agilent (A) Boosts LCMS Portfolio With New Systems Launch
Agilent Technologies (A) strengthens its Life Sciences & Applied Markets Group (LSAG) segment with 6495 LC//TQ and Revident LC/Q-TOF.
Published on: 2023-06-07 13:19:04
Impact on Symbol / Company: A
View News
U.S. Wide-Moat Stocks On Sale - The June 2023 Heat Map
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may be worth your time for further analysis.
Published on: 2023-06-06 12:25:12
Impact on Symbol / Company: A
View News
Agilent Technologies Stock: Starting To Look Appealing
Agilent Technologies, Inc. stock has long traded at a premium valuation. The company has traditionally performed well, thanks to a solid positioning and continued M&A efforts.
Published on: 2023-05-25 18:34:41
Impact on Symbol / Company: A
View News
Goldman Sachs Maintains Agilent Technologies Buy Recommendation
Fintel reports that on May 24, 2023, Goldman Sachs maintained coverage of Agilent Technologies (NYSE:A) with a Buy recommendation.
Published on: 2023-05-24 22:34:14
Impact on Symbol / Company: A
View News
Agilent (A) Q2 Earnings Match Estimates, Revenues Rise Y/Y
Agilent Technologies' (A) second-quarter fiscal 2023 results reflect strength across LSAG and ACG segments.
Published on: 2023-05-24 14:28:16
Impact on Symbol / Company: A
View News
Why Agilent Technologies Stock Is Sinking Today
Agilent topped Wall Street's consensus earnings estimate in its latest quarter. However, market uncertainties caused the company to provide weaker-than-expected guidance.
Published on: 2023-05-24 12:55:49
Impact on Symbol / Company: A
View News
Agilent Technologies stock tumbles after it lowers outlook for its fiscal year
Agilent Technologies (NYSE:A) Inc stock tumbled after it cut its outlook for its fiscal year 2023 while noting that demand from biotech companies had dried up in the difficult environment. “We expect this constrained capital environment to remain in place throughout the course of our fiscal year.
Published on: 2023-05-24 12:42:58
Impact on Symbol / Company: A
View News
Agilent Gets a Downgrade After Strong Earnings. Here's Why.
The laboratory instruments maker posted earnings of $1.27 per share, better than the $1.26 expected by analysts.
Published on: 2023-05-24 09:00:00
Impact on Symbol / Company: A
View News
Agilent Technologies, Inc. (A) Q2 2023 Earnings Call Transcript
Agilent Technologies, Inc. (NYSE:A ) Q2 2023 Earnings Conference Call May 23, 2023 4:30 PM ET Company Participants Parmeet Ahuja - IR Mike McMullen - President and CEO Robert McMahon - SVP and CFO Padraig McDonnell - President, Agilent CrossLab Group Sam Raha - President, Agilent Diagnostics & Genomics Group Jacob Thaysen - President, Agilent Life Science & Applied Markets Group Conference Call Participants Brandon Couillard - Jefferies Vijay Kumar - Evercore ISI Puneet Souda - SVB Securities Matt Sykes - Goldman Sachs Rachel Vatnsdal - JPMorgan Dan Leonard - Credit Suisse Mike Ryskin - Bank of America Dan Brennan - TD Cowen Jack Meehan - Nephron Patrick Donnelly - Citi Josh Waldman - Cleveland Research Liza Garcia - UBS Operator Ladies and gentlemen, welcome to the Agilent Technologies' Q2 2023 Earnings Call. My name is Sarah, and I will be coordinating your call today.
Published on: 2023-05-23 20:51:08
Impact on Symbol / Company: A
View News
Agilent Technologies (A) Meets Q2 Earnings Estimates
Agilent Technologies (A) came out with quarterly earnings of $1.27 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $1.13 per share a year ago.
Published on: 2023-05-23 18:40:10
Impact on Symbol / Company: A
View News
Agilent shares fall after ‘increased market uncertainties' weigh on outlook
Shares of Agilent Technologies Inc. A, -0.35% fell after hours on Tuesday after the laboratory-equipment maker cut its full-year outlook to reflect “increased market uncertainties” and issued a weaker-than-expected third-quarter forecast. The company said it expected full-year sales of $6.93 billion to $7.03 billion, compared to a prior forecast of $7.03 billion to $7.1 billion given in February.
Published on: 2023-05-23 17:15:00
Impact on Symbol / Company: A
View News
Agilent to Present at Jefferies and Goldman Sachs Healthcare Conferences
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the company will participate in Q&A sessions at the Jefferies and Goldman Sachs healthcare conferences. Below are details of each session. Jefferies Global Healthcare Conference Mike McMullen, Agilent President and CEO Wednesday, June 7 9:00 – 9:25 a.m. ET / 6:00 – 6:25 a.m. PT Goldman Sachs 44th Annual Global Healthcare Conference Bob McMahon, Agilent CFO Tuesday, June 13 1:00 – 1:40 p.m. ET / 10.
Published on: 2023-05-22 18:00:00
Impact on Symbol / Company: A
View News
Grow your Money
We helps you in understanding the science behind growing the money, which will help you diversify your funds as per your requirements and helps in achieving your retirement goals, children education, investment in property, business or any smart looking startup ventures
Services we Offer
We offer several services including expert recommendations & suggestions on buying ETF, Mutual Funds, Bonds, Debt securities, Equities, Property invesments and several others
Live Market Data
We provide you live market data for your analysis, review and looking out for quick buying opportunities to help you